Previous
Adelaide United
Melbourne Victory
2
2
FT
Game Details
Shandong Luneng Taishan
Liaoning Whowin
3
1
FT
Game Details
West Ham United
Brighton & Hove Albion
0
3
FT
Game Details
France
England
1
0
FT
Game Details
Schalke 04
Mainz
2
0
FT
Game Details
St Etienne
Montpellier
0
1
FT
Game Details
FC Groningen
Willem II Tilburg
0
1
FT
Game Details
Morelia
León
0
0
FT
Game Details
Atlas
Tijuana
1
0
FT
Game Details
Melbourne City FC
Wellington Phoenix FC
6:35 AM UTC
Game Details
Next

Transfer Rater: Woodburn to Barcelona

Transfers
Read

Transfer Rater: Benteke to Chelsea

Transfers
Read

Transfer Rater: Rashford to Real Madrid

Transfers
Read

Transfer Rater: Alonso to Barca, Vardy to Chelsea

Transfers
Read

Transfer Rater: Bertrand to City, Alaba to Real

Transfers
Read
ESPN FC  By ESPN staff

Barcelona defender Thomas Vermaelen to have medical at Roma

Barcelona have confirmed that defender Thomas Vermaelen is to undergo a medical with Roma.

The club said on their official Twitter account: "With the Club's permission, Thomas Vermaelen has travelled to Rome to undergo a medical with AS Roma."

On Saturday, Roma boss Luciano Spalletti said that he hoped to sign the former Arsenal player.

Vermaelen, 30, joined Barca from the Gunners in 2014 but has struggled with injuries throughout his time at the Camp Nou.

Spalletti said Roma sporting director Walter Sabatini had opened talks over the Belgium international.

"Walter is working on this deal, although for now we cannot say that it is done," he told Sky Sport.

He added: "Vermaelen is a player with experience and quality. He can build the play from the back and has great character.

"These players are used to playing important European matches."

Follow @ESPNFC on Twitter to keep up with the latest football updates.

Comments

Use a Facebook account to add a comment, subject to Facebook's Terms of Service and Privacy Policy. Your Facebook name, photo & other personal information you make public on Facebook will appear with your comment, and may be used on ESPN's media platforms. Learn more.